Differentiated Therapeutics is a differentiated therapeutics provider focused on computational prediction and optimization of targeted protein degraders (TPDs) and the discovery and development of translational medicines to treat patients with life-changing diseases, designed and developed for patients with unmet medical needs Disease-modifying TPD therapy. Differentiated Therapeutics (dx/tx) recently announced the completion of $5 million in seed financing, led by Curie.Bio.
This article is reproduced from: https://www.itjuzi.com/investevent/13438515
This site is for inclusion only, and the copyright belongs to the original author.